• Corpus ID: 23344392

Update Course II : Inflammatory Myopathies / Myotonic Disorders

  title={Update Course II : Inflammatory Myopathies / Myotonic Disorders},
  author={Richard J. Barohn and Steven A. Greenberg and Bassam F. Al Bassam and Bakri H. Elsheikh and Annabel K. Wang and Gregory T Carter and Andrew W. Tarulli},

Figures from this paper


A new explanation for recessive myotonia congenita
The data indicate that copy number variation in CLCN1 may be an important cause of recessive MC, and indicates that additional, as yet unidentified, genetic mechanisms account for cases not currently explained by either C LCN1 point mutations or exonic deletions or duplications.
Phase II Therapeutic Trial of Mexiletine in Non-Dystrophic Myotonia
Mexiletine at a dose of 200 mg three times daily is effective therapy for symptoms and signs of myotonia in patients with NDM, without study-related serious adverse events.
Refined exercise testing can aid dna‐based diagnosis in muscle channelopathies
To improve the accuracy of genotype prediction and guide genetic testing in patients with muscle channelopathies, specialized electrophysiological exercise test parameters were applied and refined.
The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment.
The non-dystrophic myotonias are an important group of skeletal muscle channelopathies electrophysiologically characterized by altered membrane excitability and there are important unresolved issues the authors address.
Redefining the clinical phenotypes of non-dystrophic myotonic syndromes
The phenotypical characteristics of NDM in both ClCh and NaCh are redefined to help clinicians working in outpatient clinics to perform a focused genetic analysis of either CLCN1 or SCN4A.
Differential diagnosis of myotonic disorders. AANEM monograph #27. Muscle Nerve 2008;37:293-299
  • 2008
Nondystrophic myotonias and periodic paralysis. Neuromuscular Disorders, 1st ed
  • 2008
Chloride channel myotonia: exon 8 hot-spot for dominant-negative interactions.
Molecular expression studies of the new exon 8 of CLCN1 mutations indicate that this region of the chloride channel has an important role in dominant negative interactions between the two chloride channel monomers, confirming the high degree of genetic heterogeneity associated with this disease.
Cold extends electromyography distinction between ion channel mutations causing myotonia
An easy electromyography (EMG) protocol combining repeated short exercise and cold as provocative tests to discriminate groups of mutations is designed.
Drug treatment for myotonia.
It is impossible to determine whether drug treatment is safe and effective in the treatment of myotonia due to insufficient good quality data and lack of randomised studies, but small single studies give an indication that clomipramine and imipramines have a short-term beneficial effect and that taurine has a long- term beneficial effect on myOTonia.